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ABSTRACT 
Objective: This study was conducted to evaluate the mangosteen (Garcinia mangostana) pericarp ethanolic extract (MPEE) properties in preventing obesity as well as its associated metabolic syndrome by analyzing the liver histology and measuring resistin, leptin, and adiponectin in the rats fed high-fat diet.  
Methods: The experimental study with male Wistar rats was conducted for 9 w, with rats divided into 5 treatment groups which were normal (standard diet), control (high-fat diet), dose 1 (high-fat diet, MPEE 200 mg/kg b.w.), dose 2 (high-fat diet, MPEE 500 mg/kg b.w.), and orlistat (high-fat diet, orlistat 21.6 mg/kg b.w.) groups. The fat and liver index were calculated at the last day of the experiment. The liver was collected for the histology analysis while the serum was collected for quantification of resistin, leptin, and adiponectin level by enzyme-linked immunosorbent assay (ELISA) method.  
Results: MPEE significantly reduced the liver index and total fat index compared to the control group. The rats treated with MPEE have the better liver condition than untreated rats, showed by lower histopathological score and lipid droplets, as well as higher percentage of functional cytoplasm. The MPEE also able to reduce the resistin and leptin level in high-fat diet rats, and slightly increase the adiponectin level. MPEE have better activities in all parameter compared to commercially available anti-obesity drug orlistat.  
Conclusion: The mangosteen pericarp ethanolic extract (MPEE) has high potential as anti-obesity drugs, clinical and toxicology studies should be pursued for further application to human.  
Keywords: Garcinia mangostana, Obesity, Fatty liver, Insulin resistance, Resistin, Adiponectin, Leptin © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)  
INTRODUCTION Mangosteen (Garcinia mangostana Linn), which is presumably originated from Southeast Asia, has long over the years been used as traditional remedies in several countries such as Sri Lanka, Malaysia, Philippines, Thailand, and India [1]. The thick mangosteen rind usually used to treat some health disorder such as cystitis, diarrhea, dysentery, eczema, fever, intestinal ailments, and other skin ailments [2, 3].  Mangosteen pericarp constituted by numerous polyphenolic acids such as xanthones and tannins. Four major xanthones identified from mangosteen pericarp are α-mangostin, β-mangostin, γ-mangostin, and methoxy-β-mangostin [2]. Xanthones from mangosteen have been widely studied for its medicinal properties; several known activities from xanthones are antioxidant, antitumor, anti-inflammatory, anti-allergy, antibacterial, antifungal, and antiviral [1].  Recently, the potential of mangosteen as anti-obesity also became the main focus in several current studies. Synthetic drugs for obesity such as orlistat and sibutramine have some negative side effects upon its use. Therefore, the usage of natural products that relatively safe as alternative therapy is much preferred [4]. Obesity is characterized by an increase in the size and the number of adipocytes, which is fat storage cells in the body, due to an imbalance between energy intake and expenditure [5, 6]. By 2030, it was predicted that the number of overweight and obese adults escalated to 1.35 billion and 573 million individuals [7]. Obesity has been known to relate to numerous health impairment and diseases such as cardiovascular disease, cancer, type 2 diabetes mellitus, and osteoarthritis [8]. Hence, finding a way to treat and/or preventing obesity became a pressing need.  Obesity frequently associated with hyperglycemia, hyperlipidemia, insulin resistance, inflammation and oxidative stress, curtailing those factors could be used as a therapeutic or preventive mechanism to combat the pathogenesis of metabolic syndrome caused by obesity [9]. 
Resistin, adiponectin, and leptin have been known to play a role in insulin sensitivity [10]. Resistin, a peptide hormone produced by mature adipocytes, regulates whole-body insulin sensitivity [11]. Adiponectin is adipose tissue-specific factors that presumed to be able to improve insulin sensitivity and inhibit vascular inflammation. Furthermore in obese subjects, the serum adiponectin levels reported to be low and increase after weight loss [12]. Leptin contributes to the control of body fat storage through regulation of feeding behavior, metabolism, and energy balance [13]. Recent studies also revealed a correlation between leptin and insulin resistance [10].  There are a number of studies regarding the anti-obesity-related mechanism of mangosteens, such as mangosteen reduced inflammation in overweight and obese individuals [14], α-mangosteen as anti-adipogenesis by reduction of peroxisome proliferator activated receptor-gamma (PPARγ) expression [15], and inhibition of fatty acid synthase (FAS) activity by α-mangostin [16]. To the best of our knowledge, no other study regarding mangosteen effect towards leptin, adiponectin, and resistin level in high-fat-induced rats has been conducted. Therefore, in this research, we studied the effect of mangosteen pericarp ethanolic extract towards resistin, adiponectin, and leptin level as the mechanism to prevent obesity in male Wistar rats fed with high-fat diet.  
MATERIALS AND METHODS 
Mangosteen pericarp ethanolic extracts preparation  The mangosteen (Garcinia mangostana L.) fruit was obtained from Indonesian farms in Cicantayan, Sukabumi, Bandung, West Java, Indonesia. The plants were identified by an herbarium staff from Departement of Biology, School of Life Science and Technology, Bandung Institute of Technology, Bandung, Indonesia. The pericarp was collected from mangosteen fruit, then dried and ground into small pieces. Subsequently, it was extracted using reflux method in water and 50% of ethanol. The extract was then freeze-dried and mangosteen pericarp ethanolic extract (MPEE) in dried powder form was produced [17].  
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marker of insulin resistance [24]. Histologic evaluation is the standard method to evaluate the presence and severity of fatty liver [25]. Therefore, we histologically analyzed the liver section of the experimental rats. In this present study, we demonstrated that rats in dose 1 (high-fat diet, MPEE 200 mg/kg b.w.) and dose 2 (high-fat diet, MPEE 500 mg/kg b.w.) have relatively normal lipid droplet and moderate lipid droplet respectively, compared to the control group (high-fat diet) which has relatively higher lipid droplet (fig. 4). In accordance with other studies, high-fat diet could induce obesity, hyperinsulinemia, and hyperglycemia, as well as steatosis, lobular inflammation, hepatocyte necrosis in the liver of rats [26, 27]. The current study showed that MPEE has the ability to lower the lipid droplet in the liver, especially MPEE with the concentration of 200 mg/kg b.w. (dose 1). From the fig. 3 it also revealed that the treatments of MPEE were able to decrease the toxicity effect of obesity-induced condition (high-fat diet) toward the liver, further demonstrating that MPEE have a beneficial effect toward metabolic syndrome that often connected with obesity. This result was supported by Chivapat et al. [28] study, which reported that mangosteen pericarp extract at the doses of 10, 100, 500, and 1000 mg/kg/day did not produce any open pharmacotoxic signs and abnormalities in hematological values of Wistar rats.  Metabolic syndrome in obese individuals such as fatty liver is mainly associated with excess calorie and saturated fat intake, which leads to the increase of visceral adipose tissue (VAT) [24]. The metabolically active VAT produced a lot of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and C-reactive protein (CRP) and correlated with reduction of adiponectin, causing hyperinsulinemia and insulin resistance [24]. This insulin resistance can lead to hepatic steatosis [24]. The adipose tissue regulates insulin sensitivity through the adipocytokines including resistin, leptin, and adiponectin [10]. Resistin, a member of cysteine-rich proteins, can increase blood glucose and plasma insulin levels as well as limits the hypoglycemic response to insulin infusion [29]. Likewise, it also suppresses insulin-stimulated glucose uptake thus decreasing insulin sensitivity [30]. Leptin is able to regulate appetite and weight in humans and rodents, by affecting central circuits in the hypothalamus and suppressing food intake as well as stimulating energy expenditure [13]. In the condition of overfeeding or increase of calorie intake, the increased flux of glucose in the muscle and adipose cells caused peripheral insulin resistance and increase of leptin biosynthesis, but it is failed to restrain feeding behavior and prevent weight gain or called as leptin resistance [31]. Adiponectin, which belongs to the collagen superfamily is exclusively expressed in mature adipocytes [13]. Adiponectin has several beneficial effects related to the obesity and obesity-linked disease, such as reduce dyslipidemia, decrease body weight, reduce insulin resistance, and decrease hepatic glucose production thus reduce blood glucose level [13, 32].  In obese as well as high-fat fed mice, it has been reported that the leptin and resistin level was elevated, whilst adiponectin level was lowered [13]. Likewise, in this study, the similar condition was observed in the high-fat diet rats (control group), which was leptin and resistin concentration were higher than the standard diet rats (normal group) and the adiponectin concentration was lower (fig. 5-7). On the other hand, the mangosteen treatments showed beneficial effect toward the leptin, resistin, and adiponectin level in high-fat diet rats. The high-fat diet rats treated with MPEE in the concentration of 200 mg/kg b.w. (dose 1) and 500 mg/kg b.w. (dose 2) had significantly lower resistin and leptin level than the control group (fig. 5 and 7), indicated that it succeed in reducing both resistin and leptin levels in the obese-induced condition. MPEE in the concentration of 500 mg/kg b.w. also showed to be able slightly increased adiponectin level, even though it was not significant (fig. 6). The activity of MPEE toward leptin, resistin, and adiponectin seem to be higher than orlistat, which was a drug that usually used for inducing weight loss in obese individuals by inhibits gastric and pancreatic lipase and reduces fat absorption [33]. This means that MPEE might be a better alternative therapy than orlistat as anti-obese drugs.  The ability of mangosteen in lowering the leptin and resistin along with increasing the adiponectin level could lead to the improvement of insulin resistance [13, 34]. By decreasing the insulin resistance, 
hepatic steatosis might as well reduce [24]. This might explained the results of the current study that showed high-fat diet rats treated with MPEE had better liver histology than the untreated high-fat diet rats. The properties of MPEE in lowering fat in the liver might be also strongly due to its xanthone contents. The α-mangostin was proved to be able to recover hepatic steatosis through hepatic SirT1-AMPK and PPARγ pathways [35].  
CONCLUSION The present study revealed that mangosteen pericarp ethanolic extract (MPEE) displayed a strong potential to prevent obesity and development of metabolic syndrome in the high-fat diet male Wistar rats than orlistat. The MPEE could reduce body weight gain and fat storage, as well as lipid droplet in the liver. MPEE also have lower toxicity effect toward the liver of the rats compared with the untreated rats. Finally, it has a potential to improve insulin resistance by decrease the leptin and resistin concentration and slightly increase adiponectin concentration. The clinical and toxicological studies should be pursued in order to determine the safe and non-toxic concentration for further application as anti-obesity drugs.  
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